Kimmel Carter is proud to support the Leukemia and Lymphoma Society (LLS).
The Leukemia & Lymphoma Society funds leading research for every type of blood cancer, including leukemia, lymphoma, myeloma, and other rare types of blood cancers. As the largest nonprofit funder of cutting-edge blood cancer research to advance cures, LLS has invested nearly $1.3 billion in cancer research since 1949, leading to breakthroughs in immunotherapy, genomics and personalized medicine that are improving and saving the lives of patients.
Since 2017 the Leukemia and Lymphoma Society has helped advance 60 of the 71 blood cancer treatment options approved by the U.S. Food and Drug Administration.
Kimmel Carter is honored to support this organization as it pioneers research at nearly 100 medical institutions worldwide, ensuring the possibility of curing blood cancer.
